Home
>
National Drug Code (NDC)
>
Carimune
Carimune - 44206-417-06 - (HUMAN IMMUNOGLOBULIN G)
Drug Information of Carimune
| Product NDC: | 44206-417 |
| Proprietary Name: | Carimune |
| Non Proprietary Name: | HUMAN IMMUNOGLOBULIN G |
| Active Ingredient(s): | 6 g/1 & nbsp; HUMAN IMMUNOGLOBULIN G |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Carimune
| Product NDC: | 44206-417 |
| Labeler Name: | CSL Behring AG |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA102367 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20090210 |
Package Information of Carimune
| Package NDC: | 44206-417-06 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (44206-417-06) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (44206-417-91) |
NDC Information of Carimune
| NDC Code | 44206-417-06 |
| Proprietary Name | Carimune |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (44206-417-06) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (44206-417-91) |
| Product NDC | 44206-417 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | HUMAN IMMUNOGLOBULIN G |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20090210 |
| Marketing Category Name | BLA |
| Labeler Name | CSL Behring AG |
| Substance Name | HUMAN IMMUNOGLOBULIN G |
| Strength Number | 6 |
| Strength Unit | g/1 |
| Pharmaceutical Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |
